| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.26 | 5e-07 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.19 | 8e-07 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |